of Mycobacterium tuberculosis by means of luciferase reporter phages. Science l993; 260: 819-822.
15. Shah JS, Liu J, Buxton D, et al.: Q-beta replicase-amplified assay for detection of Mycobacterium tuberculosis directly from clinical specimens. J Clin Microbiol 1995; 33: 1435-1441.
16. Abe C, Hirano K, Wada M, et al.: Detection of Mycobacterium tuberclosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium tuberculosis Direct Test. J Clin Microbiol 1993; 31: 3270-3274.
17. Zhang Y, Heym B, Allen B, et al.: The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 591-593.
18. Altamirano M, Marostenmeki J, Wong A, et al.: Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J Infect Dis 1994; 169: 1162-1165.
19. Banerjee A, Dubnau E, Quemad A, et al.: inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230.
20. Telenti A, Imboden P, Marchesi F, et al.: Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 342: 647-650.
21. Williams DL, Waguespack C, Eisenach K, et al.: Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994; 38: 2380-2386.
22. Finken M, Kirschner P, Meier A, et al.: Molecular basis of streptomycin resistance in Mycobacterium tuberculosis; Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Micrcobiol 1993; 9: 1239-l246.
23. Douglass J and Steyn LM: A ribosomal gene mutation in streptomycin resistant Mycobacterium tuberculosis isolates. J Infect Dis 1993; 167: 1505-1506.
24. Cambau E, Sougakoff W, Besson M, et al.: Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J Infect Dis 1994; 170: 479-483.
25. Takiff H, Guerrero C, Phillip W, et al.: Mutations in the gyrase A gene (gyrA) of Mycobacterium tuberculosis confer resistance to fluoroquinolones. In Program and on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, D. C., ASM, 1993.
26. Scorpio A and Zhang Y: Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antitubereculous drug pyrazinamide in tubercle bacillus. Nature Med 1996; 2: 662-667.
27. Hirano K, Takahashi M, Kazumi Y, et al.: Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis l998; 78: 117-122.
28. Kapur V, Li L-L, Hamrick MR, et al.: Rapid mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 1995; 119: 131-138.
29. Ilayashi K: PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic PCR. PCR Methods Applications 1991; 1: 34-38.
30. Williams DL, Spring L, Gillis TP, et al.: Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis 1998; 26: 446-450.
31. Rossau R, Traore H, Beenhouwer HD, et al.: Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrobial Agents Chemother 1997; 41: 2093-2098.
32. Piatek A, et al.: Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis Nature Biotech 1998; 16: 359-363.
